What is Eli Lilly Tokenized bStocks (LLYB)?
Quick Facts
- Token symbol: LLYB
- Blockchain: BNB Smart Chain (BSC)
- Backed by: Real Eli Lilly (LLY) shares held in a regulated SPV
- Issuer: BTECH Holdings Ltd, a Binance group affiliate
- Regulatory status: Admitted to FSRA's Official List of Securities (Abu Dhabi Global Market)
- Trading: 24/7 on Binance Spot Market and margin products
- Backing model: 1:1, with daily on-chain Proof of Collateral
Introduction
LLYB is a tokenized stock representing shares of Eli Lilly and Company, one of the world's leading pharmaceutical firms. It is issued under the bStocks platform, built on BNB Smart Chain, and provides holders with full economic exposure to Eli Lilly's equity performance — accessible around the clock from a crypto wallet.
bStocks bridges traditional equity markets and decentralized infrastructure, allowing traders to hold, trade, and use stock-linked tokens without ever leaving the blockchain ecosystem.
History & Background
bStocks is a tokenized securities platform developed by BTECH Holdings Ltd, a Binance group affiliate. The platform operates under a regulatory framework approved by the Financial Services Regulatory Authority (FSRA) of the Abu Dhabi Global Market. Binance, acting as a Recognised Investment Exchange, lists bStocks tokens with institutional-grade market surveillance.
LLYB was launched alongside other bStocks products as Binance expanded its tokenized equity offerings. In 2026, LLYB was added as eligible collateral across Binance's Cross Margin, Portfolio Margin, and Portfolio Margin Pro products — marking a significant step in the convergence of crypto and traditional finance.
How Eli Lilly Tokenized bStocks Works
Every LLYB token is minted 1:1 against a real Eli Lilly share held by a regulated US broker-custodian inside a Special Purpose Vehicle (SPV). The SPV is ring-fenced and bankruptcy-remote, meaning the underlying shares are segregated from BTECH Holdings' own assets.
Smart contracts on BNB Smart Chain handle minting and redemption. A built-in rebase mechanism automatically accounts for corporate actions such as dividends and stock splits — no manual airdrops are required. Users can convert between LLYB and the underlying share at a 1:1 ratio with zero fees, and withdraw tokens to any BSC-compatible self-custody wallet.
On-chain Proof of Collateral is reconciled in real time and published daily, providing public, verifiable proof that every token in circulation is backed by a real share.
Tokenomics
LLYB's supply is fully demand-driven. Tokens are minted only when new Eli Lilly shares are purchased and placed into custody, and burned when shares are redeemed. This keeps the token supply in strict lockstep with the actual number of shares held in the SPV. The economic design ensures no dilution and no uncollateralized issuance.
Dividends and other corporate distributions are handled automatically through the rebase mechanism, preserving accurate per-token economic exposure at all times.
|
Circulating Supply
| 664 LLYB |
|---|---|
|
Total supply
| 664 LLYB |
|
Max supply
| -- LLYB |
Ecosystem & Use Cases
- Spot trading: LLYB/USDT is available on Binance Spot 24/7, allowing continuous equity exposure outside traditional market hours.
- Margin collateral: LLYB can be used as eligible collateral in Binance's Cross Margin and Portfolio Margin products.
- Self-custody: Users can withdraw LLYB to any BSC-compatible wallet, holding tokenized equity entirely on-chain.
- Convert: Binance Convert supports fee-free exchanges involving LLYB.
Team, Governance & Community
LLYB is issued and governed by BTECH Holdings Ltd, operating within the Binance group. The regulatory framework is set by the FSRA in Abu Dhabi. As a regulated tokenized security, LLYB does not use decentralized governance; instead, compliance, collateral management, and product decisions are managed by the issuing entity and its regulated custodians.
Advantages
- Full backing: Every token is 1:1 collateralized by a real Eli Lilly share in a regulated, ring-fenced SPV.
- 24/7 trading: Access equity exposure outside traditional stock market hours.
- Regulatory oversight: Admitted to FSRA's Official List under a formal prospectus framework.
- Automatic corporate actions: Dividends and splits handled seamlessly via on-chain rebase.
- Self-custody: Users retain full control by withdrawing to their own BSC wallets.
- DeFi utility: Usable as margin collateral, unlocking leverage against tokenized equity positions.
Risks & Challenges
- Geographic restrictions: bStocks are not publicly offered in all jurisdictions where Binance operates; eligibility varies by region.
- Custodial risk: Although ring-fenced, the underlying shares depend on a regulated broker-custodian operating correctly.
- Regulatory uncertainty: The broader tokenized securities landscape remains subject to evolving laws across jurisdictions.
- Underlying asset risk: LLYB tracks Eli Lilly's stock performance, meaning holders are exposed to the pharmaceutical company's business and market risks.
- Centralized issuance: Unlike native crypto assets, LLYB relies on a centralized issuer and regulated infrastructure.
Long-Term Vision
bStocks aims to make global equity markets continuously accessible to anyone with a crypto wallet, removing the barriers of market hours, geographic restrictions, and traditional brokerage requirements. As BNB Chain has become the leading blockchain for tokenized stocks — surpassing $1 billion in tokenized equities — LLYB sits within a rapidly growing real-world asset (RWA) ecosystem. The long-term trajectory points toward deeper integration between tokenized equities and DeFi protocols, with products like LLYB serving as the bridge between the on-chain economy and traditional financial markets.
Frequently Asked Questions
- What is LLYB?
LLYB is the Eli Lilly Tokenized bStock, a BNB Smart Chain token that tracks the share price of Eli Lilly and Company. Each token is backed 1:1 by a real Eli Lilly share held in a regulated SPV.
- Who issues LLYB?
LLYB is issued by BTECH Holdings Ltd, a Binance group affiliate. It operates under a prospectus approved by the Financial Services Regulatory Authority (FSRA) of the Abu Dhabi Global Market.
- Is LLYB fully backed by real shares?
Yes. Every LLYB token is minted against a real Eli Lilly share held by a regulated US broker-custodian inside a ring-fenced, bankruptcy-remote SPV. Daily on-chain Proof of Collateral provides public verification.
- Can I trade LLYB outside of stock market hours?
Yes. LLYB trades 24/7 on Binance Spot Market, giving holders continuous exposure to Eli Lilly's equity even when traditional stock exchanges are closed.
- How are dividends and stock splits handled?
bStocks uses a built-in on-chain rebase mechanism that automatically adjusts token balances to reflect dividends and stock splits, so no manual distributions or airdrops are needed.
- Can LLYB be used as collateral?
Yes. Binance has approved LLYB as eligible collateral in its Cross Margin, Portfolio Margin, and Portfolio Margin Pro products, allowing holders to use tokenized equity to support other leveraged trades.
- Can I hold LLYB in my own wallet?
Yes. Users can withdraw LLYB from Binance to any BSC-compatible self-custody wallet, maintaining full on-chain ownership of their tokenized equity position.
- Is LLYB available everywhere?
No. bStocks are offered under a regulated prospectus and are not publicly available in all jurisdictions where Binance operates. Users should check regional eligibility before trading.